The largest database of trusted experimental protocols

2 protocols using lc 2 ad

1

Establishing and Characterizing Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The LCN1, derived from large cell neuroendocrine carcinoma, was established in our laboratory [15 (link)]. The LC-2/ad and A549, both derived from a lung adenocarcinoma, were purchased from the RIKEN BioResource Center (Ibaraki, Japan) and Japanese Cancer Research Resources Bank (Tokyo, Japan), respectively. These cells were grown in RPMI-1640 medium (SIGMA, Steinheim, Germany) supplemented with 10% fetal bovine serum (FBS; Biowest, Miami, FL, USA), 100 units/ml of penicillin, and 100 μg/ml of streptomycin (GIBCO, Auckland, New Zealand). After harvesting and washing twice with phosphate-buffered saline without divalent ions (PBS-), sub-confluent cells were stored at -80°C for proteomic analysis and fixed in 10% formalin and embedded in paraffin for immunohistochemistry. LCN1 cells were also AMeX-fixed [16 (link)] for immunohistochemical screening. The SP2/O-Ag14 cells derived from a mouse myeloma were purchased from the RIKEN BioResource Center, and were grown in RPMI-1640 medium supplemented with 1×8-azaguanine (50× Hybri-Max, SIGMA), 10% FBS, 100 units/ml of penicillin, and 100 mg/ml of streptomycin (GIBCO).
+ Open protocol
+ Expand
2

Comprehensive Cell Line Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human NSCLC cell lines RERF-LC-AI, RERF-LC-KJ, and LC2/Ad were obtained from Riken BRC through the National Bio-Resource Project of the MEXT (Tsukuba, Japan). The A549 cells were purchased from both Riken BRC and American Type Culture Collection (Manassas, VA), while the PC–9 cell line was obtained from IBL cell bank (Gunma, Japan). The genotypes of all cell lines were identified with STR Identifier (Applied Biosystems) or PowerPlex 16 STR system (Promega). All the cell lines were maintained in culture in RPMI 1640 medium with 2mM L-glutamine (Invitrogen) supplemented with 10% FBS (Sigma-Aldrich) (A549, RERF-LC-AI, RERF-LC-KJ and PC–9) or 15% FBS (LC2/Ad) and 50 U/ml penicillin streptomycin (Sigma-Aldrich) at 37°C in a humidified atmosphere with 5% CO2. For cell culture work, Gefitinib (Cayman, #13166), Docetaxel (Enzo Life Sciences, BML-T129), LY294002 (Cayman, #70920), PD98059 (Cayman, #10006726) and KU55933 (Tocris Bioscience, #3544) were dissolved in DMSO (Sigma-Aldrich). Gemcitabine (Tocris Bioscience, #3259), Pemetrexed (Santa Cruz, #sc–219564), Vinorelbine (Santa Cruz, #sc–216059), Caffeine (Tocris Bioscience, #2793) and N-acetyl-L-cysteine (NAC) (Sigma-Aldrich, #A9165) were dissolved in PBS (-).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!